InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
axelvento Free
09/09/22 11:57 AM
profile icon
axelvento Free
09/09/22 9:21 AM
profile icon
axelvento Free
09/09/22 1:25 AM
profile icon
Ecomike PremiumMember
09/08/22 7:49 PM
profile icon
axelvento Free
09/08/22 10:12 AM
profile icon
axelvento Free
09/08/22 10:09 AM
profile icon
Ecomike PremiumMember
09/08/22 1:24 AM
profile icon
axelvento Free
09/08/22 12:48 AM
profile icon
Ecomike PremiumMember
09/07/22 1:38 PM
profile icon
Ecomike PremiumMember
09/07/22 1:20 PM
profile icon
axelvento Free
09/07/22 11:04 AM
profile icon
buckysherm Free
09/07/22 8:12 AM
profile icon
buckysherm Free
09/07/22 8:09 AM
profile icon
Sunshine90 Free
09/07/22 6:29 AM
profile icon
axelvento Free
09/07/22 12:20 AM
profile icon
axelvento Free
09/07/22 12:08 AM
profile icon
axelvento Free
09/07/22 12:07 AM
profile icon
powerwalker Free
09/06/22 3:23 PM
profile icon
Ecomike PremiumMember
09/06/22 11:28 AM
profile icon
axelvento Free
09/06/22 12:45 AM
profile icon
axelvento Free
09/06/22 12:13 AM
profile icon
axelvento Free
09/04/22 2:00 AM
profile icon
axelvento Free
09/04/22 1:29 AM
profile icon
axelvento Free
09/04/22 1:12 AM
profile icon
axelvento Free
09/03/22 12:32 AM
profile icon
Ecomike PremiumMember
09/02/22 1:11 PM
profile icon
Ecomike PremiumMember
09/02/22 1:08 PM
profile icon
Ecomike PremiumMember
09/02/22 1:07 PM
profile icon
Ecomike PremiumMember
09/02/22 1:06 PM
profile icon
axelvento Free
09/02/22 12:43 PM
profile icon
Ecomike PremiumMember
09/02/22 12:29 PM
profile icon
Zorro Free
09/02/22 10:48 AM
profile icon
axelvento Free
09/02/22 9:10 AM
profile icon
axelvento Free
09/02/22 1:13 AM
profile icon
Ecomike PremiumMember
09/01/22 4:53 PM
profile icon
axelvento Free
09/01/22 12:17 AM
profile icon
chrispy2468 Free
08/31/22 10:56 PM
profile icon
Carjockey2 PremiumMember
08/31/22 4:05 PM
profile icon
Carjockey2 PremiumMember
08/30/22 12:44 PM
profile icon
Golden Cross PremiumMember
08/29/22 5:01 PM
profile icon
Ecomike PremiumMember
08/29/22 4:26 PM
profile icon
axelvento Free
08/28/22 12:15 AM
profile icon
axelvento Free
08/27/22 12:43 AM

SIGA Technologies Inc. (SIGA) RSS Feed

Followers
49
Posters
148
Posts (Today)
0
Posts (Total)
1361
Created
09/25/06
Type
Free
Moderators

SIGA Technologies, Inc. (Nasdaq: SIGA) is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug.


                                            
Possible complications of monkeypox include:
Broncho-pneumonia
Inflammation of brain tissue, viz., encephalitis
Infection of the cornea, the clear outer layer of the eye
Secondary infections
Sepsis (A life-threatening medical emergency, sepsis occurs when an infection you already have triggers a severe chain reaction throughout your body.)

 https://stockanalysis.com/stocks/siga/statistics/
Ownership Breakdown as of July 3, 2022

July 15, 2022
-SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics
https://investor.siga.com/news-releases/news-release-details/siga-announces-oncology-collaboration-kalivir-immunotherapeutics
July 12, 2022
-SIGA Announces Approximately US$28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
July 8, 2022

https://investor.siga.com/news-releases/news-release-details/siga-announces-approximately-28-million-international
-SIGA Technologies Receives Approval from UK for Tecovirimat (TPOXX®)
-Treatment Approved for Smallpox, Monkeypox, Cowpox, and Vaccinia Complications
https://investor.siga.com/news-releases/news-release-details/siga-technologies-receives-approval-uk-tecovirimat
June 23, 2022

-SIGA Announces US$13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
https://investor.siga.com/news-releases/news-release-details/siga-announces-13-million-international-procurement-orders-oral
May 31, 2022
-SIGA prepares to kick production for monkeypox treatment into high gear
https://www.pharmavoice.com/news/siga-monkeypox-treatment-tpoxx-dennis-hruby/624581/
May 19, 2022
-SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)
https://investor.siga.com/news-releases/news-release-details/siga-receives-approval-fda-intravenous-iv-formulation-tpoxxr
May 12, 2022
-New Contract Awarded by U.S. Department of Defense for the Procurement of Up to Approximately $7.5 Million of Oral TPOXX®
https://investor.siga.com/news-releases/news-release-details/new-contract-awarded-us-department-defense-procurement

SIGA Partners

Real time Monkeypox tracker with statistics, news, maps, graphs and cases count.
https://www.monkeypoxmeter.com/


Monkeypox Tally Information

Explore Library Monkeypox Tracker
https://twitter.com/ExploreLbry


Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. Readers are expected to conduct their own due diligence prior to the buying or the selling of any stock. All information here is for informational purposes only.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post